Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Public ClinicalTrials.gov record NCT03614923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Investigate Etokimab (ANB020) in Adult Subjects With Chronic Rhinosinusitis With Nasal Polyposis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the safety and efficacy of multiple doses of etokimab in adults with chronic rhinosinusitis with nasal polyps.
Study identification
- NCT ID
- NCT03614923
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Interventions
- Etokimab Biological
- Placebo Biological
- Mometasone Furoate Nasal Spray Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 29, 2018 (Actual)
- Primary completion
- Sep 2, 2020 (Actual)
- Completion
- Oct 26, 2020 (Actual)
- Last update posted
- Jan 24, 2022
2018 – 2020
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Asthma & Allergy Institute | Little Rock | Arkansas | 72209 | — |
| Alliance Research Institute | Canoga Park | California | 91304 | — |
| DaVinci Research | Roseville | California | 95661 | — |
| Sacramento Ear Nose and Throat Surgical and Medical Group Inc. - SacENT | Sacramento | California | 95815 | — |
| Allergy & Asthma Medical Group and Research Center | San Diego | California | 92123 | — |
| Colorado Allergy Asthma Centers | Denver | Colorado | 80230 | — |
| Intermed Medical Research Center | Miami | Florida | 33175 | — |
| Advanced Research Institute, Inc. | New Port Richey | Florida | 34653 | — |
| Clinical Research Consultants of Atlanta | Suwanee | Georgia | 30024 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Chicago ENT | Chicago | Illinois | 60657 | — |
| Advanced ENT and Allergy | Louisville | Kentucky | 40213 | — |
| Chesapeake Clinical Research Inc. | Baltimore | Maryland | 21236 | — |
| ENT and Allergy Associates ENTA LLP | New York | New York | 10016 | — |
| University of North Carolina Hospitals | Chapel Hill | North Carolina | 27599 | — |
| Charlotte Eye Ear Nose and Throat Associates | Matthews | North Carolina | 28105 | — |
| Ohio Sinus Institute | Dublin | Ohio | 43016 | — |
| Allergy Asthma Clinical Research Center | Oklahoma City | Oklahoma | 73120 | — |
| Allergy Asthma and Immunology Center P.C. | Tulsa | Oklahoma | 74136 | — |
| Central States Research, LLC | Tulsa | Oklahoma | 74136 | — |
| National Allergy and Asthma Research | North Charleston | South Carolina | 29420 | — |
| Fort Worth ENT Berkson Medical | Fort Worth | Texas | 76109 | — |
| Ear Nose and Throat Associates of Texas | McKinney | Texas | 75070 | — |
| Intermountain Ear Nose Throat Specialist | Draper | Utah | 84020 | — |
| Chrysalis Clinical Research | St. George | Utah | 84790 | — |
| Eastern Virginia Medical School EVMS Medical Group | Norfolk | Virginia | 23507 | — |
| Bellingham Asthma Allergy Immunology Clinic | Bellingham | Washington | 98225 | — |
| Allergy, Asthma Sinus Center, SC | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03614923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2022 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03614923 live on ClinicalTrials.gov.